In vivo depletion assays confirmed that CD40‒HER2 BsAb‐11 inhibited tumour growth mainly through macrophages, B cells and T cells, as their depletion restored tumour growth (Figures 4A,B and S5A,B). The gene discussed is ERBB2; the disease is neoplasm.